Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma
  2. Liu, Jinping; Tang, Wei; Budhu, Anuradha; Forgues, Marshonna; Hernandez, Maria O; Candia, Julián; Kim, Yujin; Bowman, Elise D; Ambs, Stefan; Zhao,Yongmei; Tran,Bao; Wu,Xiaolin; Koh, Christopher; Surana, Pallavi; Liang, T Jake; Guarnera, Maria; Mann, Dean; Rajaure, Manoj; Greten, Tim F; Wang, Zhanwei; Yu, Herbert; Wang, Xin Wei
  3. Cell. 2020, JUL 23; 182(2): 317-+.
  1. 2.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 3.   Possession of HLA Class II DRB1*1303 Associates with Reduced Viral Loads in Chronic HIV-1 Clade C and B Infection
  2. Julg, B.; Moodley, E. S.; Qi, Y.; Ramduth, D.; Reddy, S.; Mncube, Z.; Gao, X. J.; Goulder, P. J.; Detels, R.; Ndung'u, T.; Walker, B. D.; Carrington, M.
  3. Journal of Infectious Diseases. 2011, Mar; 203(6): 803-809.
  1. 4.   Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology
  2. Zhang, R. X.; Zhang, F. B.; Wang, C. J.; Wang, S. X.; Shiao, Y. H.; Guo, Z. J.
  3. Journal of Experimental & Clinical Cancer Research. 2010, Sep; 29: 7.
  1. 5.   Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology
  2. Wang, S. S.; Abdou, A. M.; Morton, L. M.; Thomas, R.; Cerhan, J. R.; Gao, X. J.; Cozen, W.; Rothman, N.; Davis, S.; Severson, R. K.; Bernstein, L.; Hartge, P.; Carrington, M.
  3. Blood. 2010, Jun; 115(23): 4820-4823.
  1. 6.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 7.   Effects of o-aminoazotoluene on liver regeneration and p53 activation in mice susceptible and resistant to hepatocarcinogenesis
  2. Timofeeva, O. A.; Eremeev, A. V.; Goloshchapov, A.; Kalashnikova, E.; Ilnitskaya, S.; Setkov, N. A.; Kobzev, V.; Buzard, G. S.; Filipenko, M. L.; Kaledin, V.; Merkulova, T. I.
  3. Toxicology. 2008 254(1-2): 91-96.
  1. 8.   Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine
  2. Mikszta, J. A.; Dekker, J. P.; Harvey, N. G.; Dean, C. H.; Brittingham, J. M.; Huang, J.; Sullivan, V. J.; Dyas, B.; Roy, C. J.; Ulrich, R. G.
  3. Infection and Immunity. 2006, Dec; 74(12): 6806-6810.
  1. 9.   Cancer stem cells - Redefining the paradigm of cancer treatment strategies
  2. Dean, M.
  3. Molecular Interventions. 2006, Jun; 6(3): 140-148.
  1. 10.   Intracellular restriction factors in mammalian cells - An ancient defense system finds a modern foe
  2. Baumann, J. G.
  3. Current HIV Research. 2006, Apr; 4(2): 141-168.
  1. 11.   Alternate polypurine tracts (PPTs) affect the Rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction
  2. Chang, K. W.; Julias, J. G.; Alvord, W. G.; Oh, J.; Hughes, S. H.
  3. Journal of Virology. 2005, NOV; 79(21): 13694-13704.
  1. 12.   Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection
  2. Thio, C. L.; Mosbruger, T. L.; Kaslow, R. A.; Karp, C. L.; Strathdee, S. A.; Vlahov, D.; O'Brien, S. J.; Astemborski, J.; Thomas, D. L.
  3. Journal of Virology. 2004, OCT; 78(20): 11258-11262.
  1. 13.   CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques
  2. Verthelyi, D.; Wang, V. W.; Lifson, J. D.; Klinman, D. M.
  3. Aids. 2004 18(7): 1003-1008.
  1. 14.   MICA and recovery from hepatitis C virus and hepatitis B virus infections
  2. Karacki, P. S.; Gao, X.; Thio, C. L.; Thomas, D. L.; Goedert, J. J.; Vlahov, D.; Kaslow, R.; Strathdee, S.; Hilgartner, M. W.; O'Brien, S. J.; Carrington, M.
  3. Genes and Immunity. 2004 5(4): 261-266.
  1. 15.   Origin and utility of the reverse dot-blot
  2. Gold, B.
  3. Expert Review of Molecular Diagnostics. 2003 3(2): 143-152.
  1. 16.   Balanced polymorphism selected by genetic versus infectious human disease
  2. Dean, M.; Carrington, M.; O'Brien, S. J.
  3. Annual review of genomics and human genetics. 2002 3: 263-292.
  1. 17.   Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes
  2. Shrestha, S.; Strathdee, S. A.; Brahmbhatt, H.; Farzadegan, H.; Vlahov, D.; Smith, M. W.
  3. Aids. 2000 14(11): 1507-1513.
  1. 18.   Critical windows of exposure for children's health: Cancer in human epidemiological studies and neoplasms in experimental animal models
  2. Anderson, L. M.; Diwan, B. A.; Fear, N. T.; Roman, E.
  3. Environmental Health Perspectives. 2000 108(Suppl 3): 573-594.
  1. 19.   Somatic mutations in the kinase domain of the MET/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
  2. Park, W. S.; Dong, S. M.; Kim, S. Y.; Na, E. Y.; Shin, M. S.; Pi, J. H.; Kim, B. J.; Bae, J. H.; Hong, Y. K.; Lee, K. S.; Lee, S. H.; Yoo, N. J.; Jang, J. J.; Pack, S.; Zhuang, Z. P.; Schmidt, L.; Zbar, B.; Lee, J. Y.
  3. Cancer Research. 1999 59(2): 307-310.
  1. 20.   HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
  2. Carrington, M.; Nelson, G. W.; Martin, M. P.; Kissner, T.; Vlahov, D.; Goedert, J. J.; Kaslow, R.; Buchbinder, S.; Hoots, K.; O'Brien, S. J.
  3. Science. 1999 283(5408): 1748-1752.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel